CN112913934A - 一种粉末中长碳链甘三酯稻米油的制备方法 - Google Patents
一种粉末中长碳链甘三酯稻米油的制备方法 Download PDFInfo
- Publication number
- CN112913934A CN112913934A CN202110311395.7A CN202110311395A CN112913934A CN 112913934 A CN112913934 A CN 112913934A CN 202110311395 A CN202110311395 A CN 202110311395A CN 112913934 A CN112913934 A CN 112913934A
- Authority
- CN
- China
- Prior art keywords
- rice oil
- carbon chain
- chain triglyceride
- long carbon
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 78
- 235000009566 rice Nutrition 0.000 title claims abstract description 78
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 title claims abstract description 66
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 240000007594 Oryza sativa Species 0.000 title 1
- 241000209094 Oryza Species 0.000 claims abstract description 77
- 239000000843 powder Substances 0.000 claims abstract description 40
- 125000005456 glyceride group Chemical group 0.000 claims abstract description 22
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims abstract description 20
- 238000003756 stirring Methods 0.000 claims abstract description 20
- 238000001694 spray drying Methods 0.000 claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 16
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 11
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 11
- 229940083466 soybean lecithin Drugs 0.000 claims abstract description 11
- 229920001353 Dextrin Polymers 0.000 claims abstract description 9
- 239000004375 Dextrin Substances 0.000 claims abstract description 9
- 235000019425 dextrin Nutrition 0.000 claims abstract description 9
- 238000005809 transesterification reaction Methods 0.000 claims abstract description 9
- 238000004945 emulsification Methods 0.000 claims abstract description 6
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 5
- 238000000265 homogenisation Methods 0.000 claims abstract description 4
- 238000005496 tempering Methods 0.000 claims abstract description 4
- 239000003921 oil Substances 0.000 claims description 85
- 235000019198 oils Nutrition 0.000 claims description 85
- 238000006243 chemical reaction Methods 0.000 claims description 30
- 239000003054 catalyst Substances 0.000 claims description 25
- 239000011162 core material Substances 0.000 claims description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 10
- 239000008347 soybean phospholipid Substances 0.000 claims description 10
- 102000011632 Caseins Human genes 0.000 claims description 9
- 108010076119 Caseins Proteins 0.000 claims description 9
- 230000001804 emulsifying effect Effects 0.000 claims description 9
- 239000000839 emulsion Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 235000018102 proteins Nutrition 0.000 claims description 9
- -1 sucrose ester Chemical class 0.000 claims description 9
- 229920002774 Maltodextrin Polymers 0.000 claims description 8
- 239000005913 Maltodextrin Substances 0.000 claims description 8
- 229940035034 maltodextrin Drugs 0.000 claims description 8
- 239000007764 o/w emulsion Substances 0.000 claims description 8
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 7
- 108010073771 Soybean Proteins Proteins 0.000 claims description 7
- 235000019710 soybean protein Nutrition 0.000 claims description 7
- 108010048733 Lipozyme Proteins 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 6
- 210000002969 egg yolk Anatomy 0.000 claims description 6
- FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 claims description 6
- 229940080237 sodium caseinate Drugs 0.000 claims description 6
- 230000009471 action Effects 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- 235000020183 skimmed milk Nutrition 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 239000008158 vegetable oil Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 229920000858 Cyclodextrin Polymers 0.000 claims description 3
- 239000001116 FEMA 4028 Substances 0.000 claims description 3
- 229920000881 Modified starch Polymers 0.000 claims description 3
- 239000004368 Modified starch Substances 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 3
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 3
- 229960004853 betadex Drugs 0.000 claims description 3
- 238000006555 catalytic reaction Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 235000019426 modified starch Nutrition 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000010495 camellia oil Substances 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- 235000021388 linseed oil Nutrition 0.000 claims description 2
- 239000000944 linseed oil Substances 0.000 claims description 2
- 235000005713 safflower oil Nutrition 0.000 claims description 2
- 239000003813 safflower oil Substances 0.000 claims description 2
- 125000004185 ester group Chemical group 0.000 claims 4
- 235000013305 food Nutrition 0.000 abstract description 18
- 230000004060 metabolic process Effects 0.000 abstract description 8
- 230000009102 absorption Effects 0.000 abstract description 7
- 238000010521 absorption reaction Methods 0.000 abstract description 7
- 235000016709 nutrition Nutrition 0.000 abstract description 7
- 230000035764 nutrition Effects 0.000 abstract description 5
- 230000029087 digestion Effects 0.000 abstract description 4
- 238000003860 storage Methods 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 21
- 150000002148 esters Chemical group 0.000 description 16
- 229940088598 enzyme Drugs 0.000 description 11
- 235000019197 fats Nutrition 0.000 description 10
- 239000004519 grease Substances 0.000 description 7
- 150000004667 medium chain fatty acids Chemical class 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 239000002960 lipid emulsion Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000003549 soybean oil Substances 0.000 description 6
- 235000012424 soybean oil Nutrition 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 230000037208 balanced nutrition Effects 0.000 description 4
- 235000019046 balanced nutrition Nutrition 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 108090001060 Lipase Proteins 0.000 description 3
- 239000004367 Lipase Substances 0.000 description 3
- 102000004882 Lipase Human genes 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229940040461 lipase Drugs 0.000 description 3
- 235000019421 lipase Nutrition 0.000 description 3
- 150000004668 long chain fatty acids Chemical class 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229940087068 glyceryl caprylate Drugs 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 235000016236 parenteral nutrition Nutrition 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 210000003240 portal vein Anatomy 0.000 description 2
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 108010004103 Chylomicrons Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002199 base oil Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000002608 ionic liquid Substances 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 229940023486 oral product Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- LKUNXBRZDFMZOK-UHFFFAOYSA-N rac-1-monodecanoylglycerol Chemical compound CCCCCCCCCC(=O)OCC(O)CO LKUNXBRZDFMZOK-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 125000005457 triglyceride group Chemical group 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
- A23D9/013—Other fatty acid esters, e.g. phosphatides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
- A23D9/04—Working-up
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
- C11C3/10—Ester interchange
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Edible Oils And Fats (AREA)
Abstract
本发明涉及一种粉末中长碳链甘三酯稻米油的制备方法,属于食品加工技术领域,其制备方法是采用辛葵酸甘油脂与稻米油酯酯交换,制成中长碳链甘三酯稻米油;再与大豆磷脂配合调质,在搅拌条件下逐渐加入到蛋白粉、糊精及乳化剂等溶液中,经乳化均质形成水包油(O/W)体系,采用喷雾干燥制得粉末中长碳链甘三酯稻米油。本发明所制得的粉末中长碳链甘三酯稻米油不但水溶和储藏稳定性优良,富含易消化吸收的脂肪、蛋白及磷脂等功能性营养成分,具有较高的能量及功能营养性,利于人体的消化吸收及代谢,可作为营养均衡、可冲饮的功能性保健油脂食品、肥胖和康复病人药膳食品、食品料包调味油等应用。
Description
技术领域
本发明涉及一种粉末中长碳链甘三酯稻米油的制备方法,属于功能性食品加工技术领域。
背景技术
随着食品行业的发展,以及人体营养健康和保健意识的增强,要求食品中含有某些特殊功能性营养成分,以及良好风味性、应用方便,储藏稳定、并对人体的消化吸收代谢等生理功能调节产生重要作用,实现“药膳同源”的功能性营养食品,倍受人们的青睐。
目前,为改变油脂的特性,采用酯交换反应使其脂肪酸和甘油酯组成、结构、性质改变,具有特殊功能和营养价值。中长碳链甘油三酯( MLCT)是天然油脂改性制备的产品,是一类新型的结构酯,由中碳链脂肪酸(MCFA)和长碳链脂肪酸(LCFA)结合于同一甘油分子上而生成的甘油三酯。MLCT除快速提供机体代谢所需的能量外,还为机体提供生物膜和生物活性物质代谢所需的中碳链脂肪酸、多不饱和脂肪酸类,防止机体必需脂肪酸的缺乏。在控制体重、体脂肪和改善载脂蛋白代谢等方面起重要作用,在食品及医药行业有重要的应用价值。
近年来,MLCT 作为静脉注射液的主成分已成功的应用于医药脂肪乳剂中,肠外营养研究表明,MLCT的脂肪乳剂可安全有效地为手术后病人提供能量,故以MLCT为基料油的结构脂肪乳剂具备成为未来静脉肠外营养主力军的潜力。将取代20世纪60年代初就应用于临床大豆油为基料油的脂肪乳剂,大豆油存在过多的多不饱和脂肪酸,以及其它热源成分易对机体免疫功能造成损伤,甚至可能导致脂质过氧化等方面的危害。
目前,国内市售MLCT的脂肪乳剂,其主要功能成分由国外进口,有关生产工艺等核心技术尚属保密。国内相关研究开发主要采用酯交换改性方法。马全国等以辛葵酸与豆油在离子液体催化剂催化酸解,徐文迪等以棕榈油与椰子油,宋志华等以中碳链甘三酯和大豆油为原料,均在脂肪酶TLIM催化作用下反应,再采用分子蒸馏蒸去未反应的酸与酯,制得液体中长链甘三酯。由于制品中热源成分、中长碳链甘三酯组成成分结构含量、相关理化质量等指标严格限制,国内制品尚未推广应用。
此外,由于油脂不溶于水,有水很容易水解或受空气氧的作用氧化酸败,与部分食品混合均匀难。国内科技工作者以高熔点(52℃-58℃)棕榈油为原料采用喷雾干燥方法研发出了粉末油脂产品,仅用于调味料市场。
发明内容
本发明的目的是制备“药膳同源”的油脂食品,实现油脂“药膳同源”功能营养性,提供一种粉末中长碳链甘三酯稻米油及其制备方法,以解决中长链甘三酯作为静脉注射液补充病人脂肪能量应用,要求中长链甘三酯中不含热源成分、甘三酯组成结构含量、相关理化质量标准和价格高,注射应用不便,以及液体油脂不适宜直接服用等问题。研发“药膳同源”的粉末中长碳链甘三酯稻米油的油脂食品,不但含丰富的中长碳链甘三酯稻米油、蛋白质、维生素E类、谷维素等功能性营养成分,而且产品中脂肪、蛋白(必需氨基酸类)及碳水化合物等营养均衡,冲饮方便,良好的储藏稳定性,经口服达体内,不受油脂中热源成分的影响,能快速水解吸收补充人体所需的三大营养素及其它功能性营养成分。相关动物及人体临床研究表明,中长碳链甘三酯(MLCT)比长碳链甘三酯(LCT)和MCT/LCT 的脂肪乳剂具有很多优势,主要包括有:提高免疫功能、降低癌症风险、抑制血栓形成、降低固醇含量、提高氮平衡、对网状内皮***无损害等。
本发明的发明机理在于:其方法采用酯酯交换技术,以辛葵酸甘油脂与精制稻米油为原料,在酶或化学催化剂的作用下,制取营养价值、功能性特殊的中长碳链甘三酯稻米油。中长碳链甘三酯稻米油与大豆磷脂经乳化调质制成芯材,然后将调制的芯材,加入麦芽糊精、蛋白粉等壁材和酪蛋白乳化剂辅料制成的混合水溶液体系中,经均质乳化制成水包油型(O/W)体系,采用喷雾干燥技术在喷雾干燥条件为进风温度为210℃,出风温度在95℃,加工成粉末中长碳链甘三酯稻米油制品。粉末中长碳链甘三酯稻米油产品,具有较高的能量和富含多种营养均衡的活性功能性成分,有利于人体的消化吸收及代谢。陆继源等酶法酯交换合成中长碳链结构酯指出,含有中碳链酸(MCFA)的结构脂进入体内后与普通甘三酯的代谢途径并不相同。结构脂被胰脂肪酶水解成甘油和FFA后,生成的游离MCFA会与甘油一起迅速穿过小肠绒毛细胞,无需形成乳糜微粒,直接进入门静脉运经循环***输至肝脏,在肝脏内也不需依赖肉毒碱载体直接进入线粒体被氧化代谢。毕艳兰著油脂化学指出,中碳链脂肪酸通过门静脉运输比长碳链脂肪酸先到肝脏,中碳链脂肪酸从肠内水解进入血液只需0.5h,2.5h可达最高峰;而长碳链脂肪酸一般需要5h。本发明研发的粉末中长碳链甘三酯稻米油可作为冲饮的功能性药膳食品,营养均衡快速补充人体能量的油脂制品,以及特殊食品料包的调味油应用。
产品所用辛葵酸甘油酯是由8~10个碳原子的脂肪酸组成的甘油三酯,简称MCT,是FDA确认为GRAS物质,在肠道内极易水解,吸收,吸收速度比一般油脂快4倍,并在肝脏和身体内不积累,体内吸收代谢速度快,具有调节脂肪代谢紊乱,降低胆固醇,预防和治疗高血脂和脂肪肝的药物。稻米油是禾谷类植物油,脂肪吸收率达95%以上,并富含维生素E、谷维素、甾醇酯等功能性营养成分。美国贝雷油脂化学与工艺学第六版,稻米油中谷维素能使总胆固醇、低密度脂蛋白胆固醇减少,高密度脂蛋白上升,甘油三酯含量显著降低,油中生育酚同样能减少血清胆固醇。稻米油的脂肪酸组成符合美国心脏病学会(AHA)推荐标准,是世界卫生组织(WHO)推荐的三大健康油之一,营养学家公认的“油中黄金”。另外,产品中磷脂是人体细胞(细胞膜、核膜、质体膜)的基本成分,对神经、生殖、激素等功能有重要关系。特别是中老年预防和治疗现代病,老年痴呆,广大妇女美容和减肥,少年儿童和青少年学生健脑益智,均需食用大豆磷脂。美国称磷脂是近30年开发的最重要营养补助制品,倍受人们的青睐。
本发明的目的是通过以下技术方案来实现的:
一种粉末中长碳链甘三酯稻米油的制备方法,是采用辛葵酸甘油脂与稻米油酯酯交换,制成中长碳链甘三酯稻米油;再与大豆磷脂配合调质,在搅拌下逐渐加入到蛋白粉、糊精及乳化剂等溶液中,经乳化均质形成水包油(O/W)体系,采用喷雾干燥制得目标产品--粉末中长碳链甘三酯稻米油。
具体包括以下步骤:
(1)化学或酶催化酯交换反应:
化学催化酯酯交换:将辛葵酸甘油脂与稻米油在化学催化剂作用下进行酯酯交换反应,反应温度25℃~120℃,反应时间20min~120min,酯交换后经水洗、真空薄膜干燥脱水制得中长碳链甘三酯稻米油;
酶催化酯酯交换:将辛葵酸甘油脂与稻米油在酶催化剂的催化作用下进行酯酯交换反应,反应温度20℃~100℃,反应时间20min~400min,酯交换后经离心分离、真空薄膜干燥制得中长碳链甘油酯的稻米油;
(2)将步骤(1)得到的中长碳链甘三酯稻米油和大豆磷脂按照10:0.1~5(W/W),在20℃~120℃下搅拌混合成均匀的芯材混合物。
(3)将蛋白粉、糊精和乳化剂在温度为20℃~110℃加热溶解后,在搅拌条件下逐渐加入芯材混合物,在压力0.5~60Mpa下均质乳化得到水包油(O/W)的乳化液,所述的蛋白粉用量为总反应体系质量的1.0~50.0%,糊精的用量为总反应体系质量的1.0~60.0 %,乳化剂的用量为总反应体系质量的0.1~10.0%;
(4)将步骤(3)所得的乳化液进行喷雾干燥,喷雾干燥的进风口温度为170℃~230℃,出风口温度在75℃~120℃,得到粉末中长碳链甘三酯稻米油。
在本发明中:
所述的稻米油也可以换为其植物油如茶油、红花油、亚麻油等。
所述的辛葵酸甘油酯也可以是其它中碳链脂肪酸甘油酯类,如辛酸甘油酯、葵酸甘油酯、月桂酸甘油酯等。
所述的化学催化剂是甲醇钠,乙醇钠、氢氧化钠/甘油等,其用量为总反应体系质量的0.1~5.0%。
所述的酶催化剂是435 (NOVOZYM)、LipozymeRMIM(NOVOZYM)、LipozymeTLIM(NOVOZYM)等脂肪酶中的任意一种,其用量为反应体系质量的0.1~25%。
所述的大豆磷脂为大豆卵磷脂(PC35~PC80)、粉末大豆磷脂、浓缩大豆磷脂、羟基化磷脂中的一种或几种任意复配。
所述的蛋白粉为鸡蛋蛋白粉、蛋黄粉、脱脂奶粉、大豆分离蛋白粉、大豆浓缩蛋白粉中的一种或几种任意复配。
所述糊精为β-环状糊精、麦芽糊精及变性淀粉中的一种或二种以上的复配物;所述乳化剂为酪蛋白钠、蔗糖酯、单甘酯中的一种或几种任意复配。
所述的辛葵酸甘油脂与稻米油的质量比为:1∶0.5~10(W/W)。
本发明相对于现有技术的有益效果是:
该方法制备的粉末中长碳链甘三酯稻米油,不但水溶和储藏稳定性优良,具有较高的能量和富含多种营养均衡的活性功能性成分,利于人体的消化吸收及代谢,与动植物油脂在人体的消化吸收5小时相比,中长碳链甘三酯稻米油吸收仅0.5小时,能快速补充人体能量及多种功能性营养素。产品是口服制品在人体内肠道水解消化吸收,其热源成分、中长碳链甘三酯组成结构含量均无严格限量,生产成本也低,可作为营养均衡、可冲饮的功能性保健营养油脂食品、老年、肥胖和康复病人药膳食品及食品料包调味油应用。
具体实施方式
下面通过实施例对本发明做进一步详细说明,这些实施例仅用来说明本发明,并不限制本发明的范围。
实施例1
在45.0kg辛葵酸甘油酯和60kg的稻米油中,加入7.5kg的435 (NOVOZYM)酶催化剂,在温度68℃,时间390min,搅拌速度为450 r/min条件下进行酯酯交换反应,反应后经离心分离去除酶催化剂、再真空薄膜干燥制得104.0kg中长碳链甘三酯稻米油。
将15.0kg的中长碳链甘三酯稻米油和1.0kg大豆卵磷脂(PC60)混合均匀制成芯材;然后称取5.0kg脱脂奶粉,鸡蛋蛋白粉4.0kg,32.0kg麦芽糊精,加入到250.0kg,75℃纯净水中搅拌均匀,再加入1.5kg乳化剂(酪蛋白钠:单甘酯,1:1,w/w),逐渐加入芯材,在乳化温度78℃,再经均质机在转速9000r/min,25Mpa的条件下均质乳化8.0min,制得水包油(O/W)的乳化液。然后把乳化液去做喷雾干燥,控制喷雾干燥条件为进风温度为195℃,出风温度在90℃,制取得到58.3kg粉末中长碳链甘三酯稻米油产品。
实施例2
在20.0kg辛葵酸甘油酯和60kg的稻米油中,加入反应体系中0.5%甲醇钠催化剂,在温度60℃,时间70min,搅拌速度为550 r/min条件下进行酯酯交换反应,反应后经水洗去除催化剂、再经真空薄膜干燥脱水制得79.3kg中长碳链甘三酯稻米油。
将15.0kg的中长碳链甘三酯稻米油和1.5kg粉末大豆磷脂混合均匀制成芯材;然后分别称取7.0kg蛋黄粉,14.0kg麦芽糊精,加入到150.0kg,85℃纯净水中搅拌均匀,再加入1.2kg乳化剂(酪蛋白钠:蔗糖酯:单甘酯,1.0:0.5:0.5w/w),逐渐加入芯材,在乳化温度80℃,再经均质机在转速6500r/min,10Mpa的条件下均质乳化10.0min,制得水包油(O/W)的乳化液。然后把乳化液去做喷雾干燥,控制喷雾干燥条件为进风温度为210℃,出风温度在90℃,制取得到38.5kg粉末中长碳链甘三酯稻米油产品。
实施例3
在25.0kg辛酸甘油酯和65kg的稻米油中,加入4.5kg的LipozymeRMIM(NOVOZYM)酶催化剂,在温度90℃,时间300min,搅拌速度为500 r/min条件下进行酯酯交换反应,反应后经离心分离去除酶催化剂、再经真空薄膜干燥脱酸制得89.2kg中长碳链甘三酯稻米油。
将25.0kg的中长碳链甘三酯稻米油和1.5kg大豆卵磷脂(PC35)混合均匀制成芯材;然后称取7.0kg脱脂奶粉,45.0kg麦芽糊精,加入到350.0kg,75℃纯净水中搅拌均匀,再加入1.6kg乳化剂(酪蛋白钠:单甘酯,2:1,w/w),然后在搅拌条件下逐渐加入芯材,在乳化温度90℃,再经均质机在转速8500r/min,25Mpa的条件下均质乳化8.0min,制得水包油(O/W)的乳化液。然后把乳化液去做喷雾干燥,控制喷雾干燥条件为进风温度为205℃,出风温度在90℃,制取得到80.0kg粉末中长碳链甘三酯稻米油产品。
实施例4
在15.0kg辛葵酸甘油酯和50.0kg的稻米油中,加入反应体系中0.3%乙醇钠催化剂,在温度65℃,时间80min,搅拌速度为600 r/min条件下进行酯酯交换反应,反应后经水洗去除催化剂、再经真空薄膜干燥脱水制得64.5kg中长碳链甘三酯稻米油。
将5.0kg的酯酯交换制得的中长碳链甘三酯稻米油和0.3kg大豆卵磷脂(PC35)混合均匀制成芯材;然后称取2.0kg变性淀粉和1.0kg大豆分离蛋白粉,1.5kg蛋黄粉溶解到50.0kg纯净水中在搅拌条件下加热到80℃,加入0.2kg酪蛋白钠乳化剂,然后在搅拌条件下逐渐加入芯材乳化搅拌1.5h,再经质机在转速7000r/min,20Mpa的条件下均质乳化12.0min,制得水包油(O/W)的乳化液。然后把乳化液去做喷雾干燥,控制喷雾干燥条件为进风口温度为205℃,出风口温度在95℃,制取得到9.9kg粉末中长碳链甘三酯稻米油产品。
实施例5
在25.0kg辛酸甘油酯和65kg的稻米油中,加入4.5kg的LipozymeRMIM(NOVOZYM)酶催化剂,在温度90℃,时间400min,搅拌速度为500 r/min条件下进行酯酯交换反应,反应后经离心分离去除酶催化剂、再经真空薄膜干燥脱酸制得89.5kg中长碳链甘三酯稻米油。
将10.0kg的中长碳链甘三酯稻米油和2.0kg浓缩大豆磷脂(PC35)混合均匀制成芯材;然后称取1.5kg大豆蛋白粉和蛋黄粉3.5kg,12.0kg麦芽糊精,加入到120.0kg,75℃纯净水中搅拌均匀,加入0.75kg乳化剂(酪蛋白钠:单甘酯;7:3w/w),然后在搅拌条件下逐渐加入芯材,在乳化温度75℃,再经均质机在转速8200r/min,15Mpa的条件下均质乳化10.0min,制得水包油(O/W)的乳化液。然后把乳化液去做喷雾干燥,控制喷雾干燥条件为进风温度为195℃,出风温度在88℃,制取得到28.5kg粉末中长碳链甘三酯稻米油产品。
实施例6
在55.0kg葵酸甘油酯和45kg的稻米油中,加入0.8kg的Na OH/甘油(1:2W/W)化学催化剂,在温度105℃,时间80min,搅拌速度为450 r/min条件下进行酯酯交换反应,反应后经离心分离去除酶催化剂、再经真空薄膜干燥脱酸制得98.2kg中长碳链甘三酯稻米油。
将15.0kg的中长碳链甘三酯稻米油和3.0kgPC45/浓缩大豆磷脂(1:0.5 W/W)混合均匀制成芯材;然后称取2.0kg大豆浓缩蛋白粉和蛋黄粉4.5kg,15.0kg麦芽糊精:β-环状糊精(8:2w/w),加入到180.0kg,86℃纯净水中搅拌均匀,再加入1.0kg乳化剂(酪蛋白钠:单甘酯,8:2w/w),逐渐加入芯材,在乳化温度82℃,再经均质机在转速7500r/min,30Mpa的条件下均质乳化6.0min,制得水包油(O/W)的乳化液。然后把乳化液去做喷雾干燥,控制喷雾干燥条件为进风温度为210℃,出风温度在95℃,制取得到34.5kg粉末中长碳链甘三酯稻米油产品。
Claims (10)
1.一种粉末中长碳链甘三酯稻米油的制备方法,其特征在于:是采用辛葵酸甘油脂与稻米油酯酯交换,制成中长碳链甘三酯稻米油;再与大豆磷脂配合调质,在搅拌下逐渐加入到蛋白粉、糊精及乳化剂等溶液中,经乳化均质形成水包油(O/W)体系,采用喷雾干燥制得目标产品--粉末中长碳链甘三酯稻米油。
2.根据权利要求1所述的粉末中长碳链甘三酯稻米油的制备方法,其特征在于:该制备方法具体包括以下步骤:
(1)化学或酶催化酯交换反应:
化学催化酯酯交换:将辛葵酸甘油脂与稻米油在化学催化剂作用下进行酯酯交换反应,反应温度25℃~120℃,反应时间20min~120min,酯交换后经水洗、真空薄膜干燥脱水制得中长碳链甘三酯稻米油;
酶催化酯酯交换:将辛葵酸甘油脂与稻米油在酶催化剂的作用下进行酯酯交换反应,反应温度20℃~100℃,反应时间20min~400min,酯交换后经离心分离、真空薄膜干燥制得中长碳链甘油酯的稻米油;
(2)将步骤(1)得到的中长碳链甘三酯稻米油和大豆磷脂按照10:0.1~5,在20℃~120℃下搅拌混合成均匀的芯材;
(3)将蛋白粉、糊精和乳化剂在温度为20℃~110℃加热溶解后,在搅拌条件下逐渐加入一定量的芯材,在压力0.5~60Mpa下均质乳化得到水包油(O/W)的乳化液;所述的蛋白粉用量为总反应体系质量的1.0~50.0%,糊精的用量为总反应体系质量的1.0~60.0 %,乳化剂的用量为总反应体系质量的0.1~10.0%;
(4)将步骤(3)所得的乳化液进行喷雾干燥,喷雾干燥的进风口温度为170℃~230℃,出风口温度在75℃~120℃,得到粉末中长碳链甘三酯稻米油。
3.根据权利要求2所述的粉末中长碳链甘三酯稻米油的制备方法,其特征在于:步骤(1)所述的稻米油也可以换为其它植物油如茶油、红花油、亚麻油。
4.根据权利要求1所述的粉末中长碳链甘三酯稻米油的制备方法,其特征在于:步骤(1)所述的辛葵酸甘油酯也可以是其它中碳链脂肪酸甘油酯,如辛酸甘油酯、葵酸甘油酯、月桂酸甘油酯。
5.根据权利要求1所述的粉末中长碳链甘三酯稻米油的制备方法, 其特征在于:步骤(1)所述的化学催化剂是甲醇钠,乙醇钠、氢氧化钠/甘油,其用量为反应体系总量的0.1~5.0%。
6.根据权利要求1所述的粉末中长碳链甘三酯稻米油的制备方法, 其特征在于:步骤(1)所述的酶催化剂是435 (NOVOZYM)、LipozymeRM IM(NOVOZYM)、LipozymeTLIM(NOVOZYM)中的任意一种,其用量为反应体系质量的0.1~25%。
7.根据权利要求1所述的粉末中长碳链甘三酯稻米油的制备方法,其特征在于:步骤(2)所述的大豆磷脂为大豆卵磷脂(PC35~PC80)、粉末大豆磷脂、浓缩大豆磷脂、羟基化磷脂中的一种或二种以上的复配物。
8.根据权利要求1所述的粉末中长碳链甘三酯稻米油的制备方法,其特征在于:步骤(3)所述的蛋白粉为鸡蛋蛋白粉、蛋黄粉、脱脂奶粉、大豆分离蛋白粉、大豆浓缩蛋白粉中的一种或二种以上的复配物。
9.根据权利要求1所述的粉末中长碳链甘三酯稻米油的制备方法,其特征在于:在步骤(3)中,所述糊精为β-环状糊精、麦芽糊精及变性淀粉中的一种或二种以上的复配物;所述乳化剂为酪蛋白钠、蔗糖酯、单甘酯的一种或二种以上的复配物。
10.根据权利要求1所述的粉末中长碳链甘三酯稻米油的制备方法,其特征在于:步骤(1)所述的辛葵酸甘油脂与稻米油的质量比为:1∶0.5~10。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110311395.7A CN112913934A (zh) | 2021-03-24 | 2021-03-24 | 一种粉末中长碳链甘三酯稻米油的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110311395.7A CN112913934A (zh) | 2021-03-24 | 2021-03-24 | 一种粉末中长碳链甘三酯稻米油的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112913934A true CN112913934A (zh) | 2021-06-08 |
Family
ID=76175730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110311395.7A Pending CN112913934A (zh) | 2021-03-24 | 2021-03-24 | 一种粉末中长碳链甘三酯稻米油的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112913934A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118120829A (zh) * | 2024-05-08 | 2024-06-04 | 东晓生物科技股份有限公司 | 一种稻米油甘油二酯油粉末油脂及其制备方法和应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103891920A (zh) * | 2012-12-25 | 2014-07-02 | 中粮营养健康研究院有限公司 | 一种含中长碳链甘油三酯的油脂组合物及其制备方法 |
CN104522188A (zh) * | 2015-01-07 | 2015-04-22 | 广州倚德生物科技有限公司 | 富含中低碳酸的粉末油脂及其制备方法 |
CN105821089A (zh) * | 2016-06-12 | 2016-08-03 | 江南大学 | 一种酶法合成中长链结构甘油三酯的方法 |
CN107712900A (zh) * | 2017-10-24 | 2018-02-23 | 宝得瑞(湖北)健康产业有限公司 | 一种功能性中长链脂肪酸甘油酯微胶囊及其生产方法 |
CN107974471A (zh) * | 2017-12-14 | 2018-05-01 | 广州白云山汉方现代药业有限公司 | 一种混合催化合成中长链结构甘油三酯的方法 |
CN109907126A (zh) * | 2019-04-18 | 2019-06-21 | 江南大学 | 一种中长碳链甘油三酯的油脂组合物及其制备方法 |
-
2021
- 2021-03-24 CN CN202110311395.7A patent/CN112913934A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103891920A (zh) * | 2012-12-25 | 2014-07-02 | 中粮营养健康研究院有限公司 | 一种含中长碳链甘油三酯的油脂组合物及其制备方法 |
CN104522188A (zh) * | 2015-01-07 | 2015-04-22 | 广州倚德生物科技有限公司 | 富含中低碳酸的粉末油脂及其制备方法 |
CN105821089A (zh) * | 2016-06-12 | 2016-08-03 | 江南大学 | 一种酶法合成中长链结构甘油三酯的方法 |
CN107712900A (zh) * | 2017-10-24 | 2018-02-23 | 宝得瑞(湖北)健康产业有限公司 | 一种功能性中长链脂肪酸甘油酯微胶囊及其生产方法 |
CN107974471A (zh) * | 2017-12-14 | 2018-05-01 | 广州白云山汉方现代药业有限公司 | 一种混合催化合成中长链结构甘油三酯的方法 |
CN109907126A (zh) * | 2019-04-18 | 2019-06-21 | 江南大学 | 一种中长碳链甘油三酯的油脂组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
周飞;王建宇;白雪斐;万国权;王翠翠;宦凌霄;曾哲灵;: "中长碳链甘油三酯的研究进展" * |
陆继源;王小三;金青哲;王兴国;: "响应面优化酶法酯交换催化合成中长链结构甘三酯" * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118120829A (zh) * | 2024-05-08 | 2024-06-04 | 东晓生物科技股份有限公司 | 一种稻米油甘油二酯油粉末油脂及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109907126B (zh) | 一种中长碳链甘油三酯的油脂组合物及其制备方法 | |
US7919526B2 (en) | Structured triglycerides and emulsions comprising same | |
CN104522188B (zh) | 富含中低碳酸的粉末油脂及其制备方法 | |
Wang et al. | Reviews of medium-and long-chain triglyceride with respect to nutritional benefits and digestion and absorption behavior | |
CN104988190A (zh) | 一种富含中链脂肪酸的结构型甘油三酯及其制备方法 | |
CN112772731A (zh) | 一种功能食用油及其制备方法和应用 | |
CN107969506A (zh) | 一种改善糖代谢的高稳定性鱼油乳及其制备方法 | |
CN113287659A (zh) | 一种功能结构油及其制备方法和应用 | |
CN112772924A (zh) | 一种功能食品专用油脂基料油及其制备方法和应用 | |
CN112913934A (zh) | 一种粉末中长碳链甘三酯稻米油的制备方法 | |
CN109845840B (zh) | 饱和脂肪酸与中长链脂肪酸结构脂质的制备方法 | |
CN116019149B (zh) | 一种特殊医学用途配方食品脂肪组件 | |
CN113747796A (zh) | 制作单酰基甘油酯油的方法和含有单酰基甘油酯油的食物产品 | |
CN111492044B (zh) | 制备甘油单酯油的方法以及含有甘油单酯油的食物产品 | |
CN101204216B (zh) | 含有二十八烷醇的咖啡伴侣及其制备方法 | |
CN112920908A (zh) | 一种辛酸癸酸月桂酸类中碳链油及其制备方法和应用 | |
Cheng et al. | Medium-and long-chain triacylglycerol: Preparation, health benefits, and food utilization | |
CN114292698A (zh) | 功能性动物油脂脱腥处理方法 | |
CN113832200A (zh) | 一种母乳化结构脂的制备方法 | |
Karrar et al. | The composition, characterisation, and health impacts of human milk lipid medium‐and long‐chain TAGs | |
CN116098951B (zh) | 一种含茶油的多种油脂肪乳注射液 | |
RU2803496C2 (ru) | Способ получения моноацилглицеридных масел и пищевых продуктов, содержащих моноацилглицеридные масла | |
CN113768005B (zh) | 一种澳洲坚果茶及其制备方法 | |
Xu et al. | Effect of 1, 3-diacylglycerol on cardiometabolic risk | |
CN115363098B (zh) | 一种甘油二酯在提高复原乳品质中的应用及零胆固醇低热量复原乳 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210608 |